Riskpilot← Back to searchSign inGet full accessARCTIC BIOSCIENCE AS
ASActiveOrg 996638812Industrivegen 42, 6155 ØrstaManufacture of oils and fats · NACE 1041Est. 201117 employees
Revenue 2024
NOK 43,5M
+29% vs 2023
EBITDA margin
-90.4%
+4% vs 2023
Equity ratio
76.2%
Financial strength
Net profit 2024
NOK -49,1M
-19% vs 2023
| Revenue | NOK 43,5M | +29% |
| EBITDA | NOK -39,3M | +4% |
| Net profit | NOK -49,1M | -19% |
| Total assets | NOK 280,5M | -7% |
| Equity | NOK 213,8M | -19% |
| Employees | 17 | — |
Legal name
ARCTIC BIOSCIENCE AS
Org number
996638812
Legal form
Aksjeselskap
NACE code
1041 · Manufacture of oils and fats
Founded
7. mars 2011
Share capital
NOK 2 695 625
Employees
17 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Identifisere og kommersialisere marine virkestoffer og alt som derved står i forbindelse, herunder deltagelse i andre selskaper og virksomheter.
Address
Industrivegen 42, 6155 Ørsta
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 690 | 2 519 | 3 549 | 8 925 | 8 030 | 11 761 | 18 448 | 24 934 | 30 132 | 20 593 | 21 515 | 34 469 | 33 750 | 43 484 |
| Staff expenses | −888 | −4 274 | −5 758 | −4 077 | −3 391 | −3 417 | −4 701 | −6 177 | −5 565 | −10 764 | −17 261 | −24 355 | −22 726 | −23 956 |
| EBITDA | −2 532 | −8 221 | −9 088 | −5 058 | −3 608 | −3 144 | −680 | −623 | −2 004 | −20 477 | −38 031 | −33 619 | −40 836 | −39 328 |
| Depreciation & amort. | −8 | −112 | −269 | −461 | −480 | −646 | −594 | −527 | −1 080 | −1 192 | −2 518 | −3 731 | −4 018 | −3 584 |
| EBIT | −2 541 | −8 334 | −9 358 | −5 519 | −4 087 | −3 790 | −1 274 | −1 150 | −3 083 | −21 669 | −40 549 | −37 350 | −44 854 | −42 912 |
| Net financials | −15 | 546 | 187 | −522 | −429 | −541 | −455 | −560 | −906 | −916 | −2 002 | 3 365 | 3 517 | −6 215 |
| Profit before tax | −2 556 | −7 788 | −9 170 | −6 041 | −4 517 | −4 331 | −1 729 | −1 710 | −3 990 | −22 585 | −42 551 | −33 985 | −41 337 | −49 127 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 556 | −7 788 | −9 170 | −6 041 | −4 517 | −4 331 | −1 729 | −1 710 | −3 990 | −22 585 | −42 551 | −33 985 | −41 337 | −49 127 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7 729 | 29 735 | 33 174 | 32 138 | 36 624 | 30 723 | 34 059 | 45 405 | 82 469 | 93 211 | 341 557 | 327 813 | 301 434 | 280 500 |
| Equity | 1 792 | 27 655 | 18 484 | 12 443 | 14 157 | 12 825 | 18 596 | 21 886 | 63 906 | 63 959 | 320 618 | 287 383 | 262 838 | 213 818 |
| Long-term debt | 1 271 | 0 | 9 060 | 9 795 | 10 036 | 9 322 | 9 230 | 8 240 | 7 159 | 6 576 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 666 | 2 080 | 5 630 | 9 900 | 12 431 | 8 576 | 6 233 | 15 278 | 11 405 | 22 676 | 20 939 | 40 429 | 38 596 | 66 682 |
| Total debt | 5 936 | 2 080 | 14 690 | 19 695 | 22 467 | 17 898 | 15 463 | 23 518 | 18 563 | 29 252 | 20 939 | 40 429 | 38 596 | 66 682 |
EBITDA margin
-90.4%
This company
15.8%
Market median
-672% vs market
20112024
Equity ratio
76.2%
This company
38.2%
Market median
+99% vs market
20112024
Return on equity
-23.0%
This company
18.4%
Market median
-225% vs market
20112024
Net profit margin
-113.0%
This company
8.1%
Market median
-1495% vs market
20112024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20112024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20112024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-02-15 – 2011-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CL Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
OA Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
HC | Board of Directors | 2021 | — | — |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ronja Capital As | Company | 12.2% | 12.2% | 2023 |
Ronja Capital Investment As | Company | 12.2% | 12.2% | 2024 |
Capra Invest As | Company | 6.1% | 6.1% | 2024 |
Mrfk Holding As | Company | 5.2% | 5.2% | 2024 |
| Individual | 4.9% | 4.9% | 2022 | |
Fjarde Ap-Fonden | Company | 4.7% | 4.7% | 2023 |
Altitude Capital As | Company | 4.2% | 4.2% | 2024 |
Vartdal Holding As | Company | 4.1% | 4.1% | 2024 |
Verdipapirfondet Delphi Nordic | Company | 3.3% | 3.3% | 2023 |
Brødrene Vartdal As | Company | 3.2% | 3.2% | 2024 |
Kotler Equity Investment Limited | Company | 2.6% | 2.6% | 2024 |
Life Capitol As | Company | 2.6% | 2.6% | 2024 |
Hawk Infinity As | Company | 2.5% | 2.5% | 2024 |
Stette Invest As | Company | 2.4% | 2.4% | 2024 |
Kjølås Stansekniver As | Company | 2.3% | 2.3% | 2024 |
Ajea Invest As | Company | 2.2% | 2.2% | 2024 |
Eggesbø Eiendom As | Company | 2.0% | 2.0% | 2023 |
Eros As | Company | 2.0% | 2.0% | 2024 |
Strand Fiskeriselskap As | Company | 1.9% | 1.9% | 2024 |
Nordnet Livsforsikring As | Company | 1.9% | 1.9% | 2024 |
Gold Coast Nutrition Nuf | Company | 1.8% | 1.8% | 2024 |
Triplenine Vedde As | Company | 1.3% | 1.3% | 2024 |
Melesio Invest As | Company | 1.2% | 1.2% | 2024 |
Em-Ka As | Company | 1.1% | 1.1% | 2024 |
Equinor Pensjon | Company | 1.0% | 1.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bakk Invest As
ARCTIC BIOSCIENCE AS Board members of ARCTIC BIOSCIENCE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christer Ludvig Valderhaug | Chief Executive Officer | 0 companies |
| Ole Arne Eiksund | Chief Executive Officer | 0 companies |
| Harald Nordal | Chairman | 0 companies |
| Olav Sindre Kriken | Board of Directors | 0 companies |
| Per Magne Eggesbø | Board of Directors | 0 companies |
| Tore Andreas Frøysa Tønseth | Board of Directors | 0 companies |
| Jostein Christian Dalland | Board of Directors | 0 companies |
| Hu Cao | Board of Directors | 0 companies |
| Jan Endre Vartdal | Board of Directors | 0 companies |
| Marita Holstad | Board of Directors | 0 companies |
| Asbjørn Solevågseide | Board of Directors | 0 companies |